{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:58:05Z","timestamp":1789066685013,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Guangzhou Clinical High-tech Project","award":["(2023C-GX03)"],"award-info":[{"award-number":["(2023C-GX03)"]}]},{"name":"Frontier Medical Technology Project of Guangzhou First People's Hospital","award":["(ZCZX01010011)"],"award-info":[{"award-number":["(ZCZX01010011)"]}]},{"name":"Guangzhou Science and Technology Plan Project","award":["(2023A04J0619)"],"award-info":[{"award-number":["(2023A04J0619)"]}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Science and Technology Bureau","doi-asserted-by":"crossref","award":["(SL2022A03J01107)"],"award-info":[{"award-number":["(SL2022A03J01107)"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to evaluate alterations in macular microstructure and blood flow density in patients with transfusion-dependent \u03b2-thalassemia (TDT) using optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA), and to explore their associations with markers of iron metabolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted involving 31 TDT patients (61 eyes) and 31 age- and sex-matched healthy controls (61 eyes) at the Affiliated Hospital of Guangdong Medical University from October 2022 to December 2023. Data collected included basic information, medical history, best-corrected visual acuity, ocular biometry, fundus photography, and OCT\/OCTA imaging. Parameters assessed comprised the thickness and blood flow density of individual macular layers, as well as choroidal stromal area, choroidal luminal area, and choroidal vascular index (CVI). Pearson correlation analysis was employed to examine relationships among macular parameters, serum ferritin (SF) levels, duration of iron chelation therapy (ICT), and other variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to healthy controls, TDT patients exhibited significant thinning of the central macular area ganglion cell layer, retinal nerve fiber layer, and ganglion cell complex (mGCC), accompanied by increased blood flow density in the deep vascular complex, nerve fiber layer vascular plexus, and deep capillary plexus (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). The choroidal stromal area was reduced (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.037), whereas CVI was elevated (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.034). Pearson correlation analysis revealed a positive correlation between central mGCC thickness and the duration of ICT (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.280,\n                      <jats:italic>P\u2009&lt;<\/jats:italic>\n                      \u20090.05),and a significant positive correlation between CVI with SF levels (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.426,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). Stepwise linear regression analysis identified the duration of ICT (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u20090.306,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.011) as a significant independent factor influencing central mGCC thickness. Similarly, SF levels significantly influenced CVI (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u20090.469,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Additionally, 62.30% of TDT patients\u2019 eyes presented with tilted optic discs, 34.43% showed tessellated fundus, and 6.56% had pseudoxanthoma elasticum.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TDT patients exhibit both macular neuroretinal thinning and increased microvascular blood flow density. CVI and central mGCC thickness may serve as potential biomarkers for monitoring iron-related ocular pathology and therapeutic efficacy. Future longitudinal studies are warranted to validate their predictive value and establish causality. Regular ocular screening is warranted in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-025-04510-0","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:49:40Z","timestamp":1765536580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Iron-associated central macular ganglion cell complex thinning and choroidal vascularity index elevation in transfusion-dependent \u03b2-thalassemia: potential OCT\/OCTA biomarkers"],"prefix":"10.1186","volume":"25","author":[{"given":"Ningfeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7969-0678","authenticated-orcid":false,"given":"Yunxia","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6528-3633","authenticated-orcid":false,"given":"Danna","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"2","key":"4510_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3969\/j.issn.1671-2587.2023.02.002","volume":"25","author":"CP Shao","year":"2023","unstructured":"Working Party on Immunohematology, Chinese Society of Blood Transfusion, Shao CP, Luo Q, Wu CL. Expert Consensus in China on Clinical Transfusion for Transfusion-dependent thalassemia (TDT) Patients [J]. J Clin Transfus Lab Med. 2023;25(2):163\u20139. https:\/\/doi.org\/10.3969\/j.issn.1671-2587.2023.02.002.","journal-title":"J Clin Transfus Lab Med"},{"key":"4510_CR2","doi-asserted-by":"publisher","unstructured":"Group RB, Hematology CS, Association CM. Chinese guideline for diagnosis and treatment of transfusion dependent \u03b2-thalassemia (2022). Zhonghua Xue Ye Xue Za Zhi. 2022;43(11):889\u2009\u2013\u200996. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2022.11.002.","DOI":"10.3760\/cma.j.issn.0253-2727.2022.11.002"},{"key":"4510_CR3","doi-asserted-by":"publisher","first-page":"111750","DOI":"10.1016\/j.ejrad.2024.111750","volume":"181","author":"X Ning","year":"2024","unstructured":"Ning X, Tan S, Peng F, et al. Organ-Specific iron overload in Non-Transfusion-Dependent thalassemia patients: insights from quantitative MRI evaluation. Eur J Radiol. 2024;181:111750. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111750.","journal-title":"Eur J Radiol"},{"issue":"9","key":"4510_CR4","doi-asserted-by":"publisher","first-page":"e31177","DOI":"10.1002\/pbc.31177","volume":"71","author":"R Wang","year":"2024","unstructured":"Wang R, Ma XH, Qin ZZ, Hu XX, Mo ZY, Zhao YY, et al. Global, regional, and National burden of thalassemia during 1990\u20132019: A systematic analysis of the global burden of disease study 2019. Pediatr Blood Cancer. 2024;71(9):e31177. https:\/\/doi.org\/10.1002\/pbc.31177.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"4510_CR5","first-page":"79","volume":"25","author":"F Akritidou","year":"2021","unstructured":"Akritidou F, Praidou A, Papamitsou T, Kozobolis V, Labiris G. Ocular manifestations in patients with transfusion-dependent \u03b2-thalassemia. Hippokratia. 2021;25(2):79\u201382.","journal-title":"Hippokratia"},{"issue":"4","key":"4510_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3760\/cma.j.cn511434-20230828-00358","volume":"40","author":"WW Li","year":"2024","unstructured":"Li WW, Chen DN, Wei YC, Zhao QW, Zhao GL. Research progress of fundus changes in severe beta thalassemia. Chin J Ocular Fundus Dis. 2024;40(4):329\u201333. https:\/\/doi.org\/10.3760\/cma.j.cn511434-20230828-00358.","journal-title":"Chin J Ocular Fundus Dis"},{"issue":"4","key":"4510_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3980\/j.issn.1672-5123.2024.4.20","volume":"24","author":"YC Wei","year":"2024","unstructured":"Wei YC, Chen DN, Li WW, Tong YN, Zhao GL. Research status of ocular changes in beta-thalassemia major. Guoji Yanke Zazhi (Int Eye Sci). 2024;24(4):601\u20136. https:\/\/doi.org\/10.3980\/j.issn.1672-5123.2024.4.20.","journal-title":"Guoji Yanke Zazhi (Int Eye Sci)"},{"issue":"10","key":"4510_CR8","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1007\/s12011-020-02508-x","volume":"199","author":"G Xu","year":"2021","unstructured":"Xu G, Li X, Zhu Z, Wang H, Bai X. Iron overload induces apoptosis and cytoprotective autophagy regulated by ROS generation in Mc3t3-E1 cells. Biol Trace Elem Res. 2021;199(10):3781\u201392. https:\/\/doi.org\/10.1007\/s12011-020-02508-x.","journal-title":"Biol Trace Elem Res"},{"key":"4510_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.redox.2015.07.018","volume":"6","author":"S Voskou","year":"2015","unstructured":"Voskou S, Aslan M, Fanis P, Phylactides M, Kleanthous M. Oxidative stress in \u03b2-thalassaemia and sickle cell disease. Redox Biol. 2015;6:226\u201339. https:\/\/doi.org\/10.1016\/j.redox.2015.07.018.","journal-title":"Redox Biol"},{"key":"4510_CR10","doi-asserted-by":"publisher","first-page":"794809","DOI":"10.3389\/fnins.2021.794809","volume":"15","author":"A Shahandeh","year":"2022","unstructured":"Shahandeh A, Bui BV, Finkelstein DI, Nguyen CT. Effects of excess iron on the retina: insights from clinical cases and animal models of iron disorders. Front Neurosci. 2022;15:794809. https:\/\/doi.org\/10.3389\/fnins.2021.794809.","journal-title":"Front Neurosci"},{"issue":"11","key":"4510_CR11","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1007\/s00417-021-05275-0","volume":"259","author":"HR AttaAllah","year":"2021","unstructured":"AttaAllah HR, Mousa SO, Omar IA. Macular microvascular changes in children with transfusion-dependent beta-thalassemia. Graefes Arch Clin Exp Ophthalmol. 2021;259(11):3283\u201393. https:\/\/doi.org\/10.1007\/s00417-021-05275-0.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"4510_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.joco.2019.01.012","volume":"31","author":"MO Ulusoy","year":"2019","unstructured":"Ulusoy MO, T\u00fcrk H, K\u0131van\u00e7 SA. Spectral domain optical coherence tomography findings in Turkish sickle-cell disease and beta thalassemia major patients. J Curr Ophthalmol. 2019;31(3):275\u201380. https:\/\/doi.org\/10.1016\/j.joco.2019.01.012. Published 2019 Feb 14.","journal-title":"J Curr Ophthalmol"},{"issue":"4","key":"4510_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.sjopt.2017.10.001","volume":"31","author":"F Uzun","year":"2017","unstructured":"Uzun F, Karaca EE, Y\u0131ld\u0131z Yerlikaya G, F\u0131nd\u0131k H, Ak\u0131n M. Retinal nerve fiber layer thickness in children with \u03b2-thalassemia major. Saudi J Ophthalmol. 2017;31(4):224\u20138. https:\/\/doi.org\/10.1016\/j.sjopt.2017.10.001.","journal-title":"Saudi J Ophthalmol"},{"key":"4510_CR14","doi-asserted-by":"publisher","unstructured":"Haghpanah S, Zekavat OR, Safaei S, Ashraf MA, Parand S, Ashraf H. Optical coherence tomography findings in patients with transfusion-dependent \u03b2-thalassemia. BMC Ophthalmol. 2022;22(1):279. https:\/\/doi.org\/10.1186\/s12886-022-02490-z.","DOI":"10.1186\/s12886-022-02490-z"},{"issue":"9","key":"4510_CR15","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/ajh.27006","volume":"98","author":"KM Musallam","year":"2023","unstructured":"Musallam KM, Lombard L, Kistler KD, Arregui M, Gilroy KS, Chamberlain C, et al. Epidemiology of clinically significant forms of alpha- and beta-thalassemia: A global map of evidence and gaps. Am J Hematol. 2023;98(9):1436\u201351. https:\/\/doi.org\/10.1002\/ajh.27006.","journal-title":"Am J Hematol"},{"issue":"1","key":"4510_CR16","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41598-017-00967-2","volume":"7","author":"K Lai","year":"2017","unstructured":"Lai K, Huang G, Su L, He Y. The prevalence of thalassemia in Mainland china: evidence from epidemiological surveys. Sci Rep. 2017;7(1):920. https:\/\/doi.org\/10.1038\/s41598-017-00967-2. Published 2017 Apr 19.","journal-title":"Sci Rep"},{"issue":"4","key":"4510_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.7499\/j.issn.1008-8830.2411001","volume":"27","author":"Committee of Thalassemia Prevention","year":"2025","unstructured":"Committee of Thalassemia Prevention and Treatment, China Maternal and Child Health Association. Subspecialty Group of Hematology, Society of Pediatrics, Chinese Medical Association; China Thalassemia Prevention and Control Collaboration Network; Editorial Board of Chinese Journal of Contemporary Pediatrics 2025 Guidelines for iron chelation therapy in thalassemia in China (2025). Zhongguo Dang Dai Er Ke Za Zhi 27 4 377\u201388 https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2411001.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"4510_CR18","doi-asserted-by":"publisher","first-page":"1056888","DOI":"10.3389\/fped.2022.1056888","volume":"10","author":"W Hui","year":"2022","unstructured":"Hui W, Xiaofeng H, Hua X, Yihan D, Yong T. Assessment of choroidal vascularity and choriocapillaris blood perfusion in Chinese preschool-age anisometropic hyperopic amblyopia children. Front Pediatr. 2022;10:1056888. https:\/\/doi.org\/10.3389\/fped.2022.1056888. Published 2022 Nov 17.","journal-title":"Front Pediatr"},{"issue":"1","key":"4510_CR19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12886-019-1189-8","volume":"19","author":"H Wang","year":"2019","unstructured":"Wang H, Tao Y. Choroidal structural changes correlate with severity of diabetic retinopathy in diabetes mellitus. BMC Ophthalmol. 2019;19(1):186. https:\/\/doi.org\/10.1186\/s12886-019-1189-8. Published 2019 Aug 16.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"4510_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/cne.903000103","volume":"300","author":"CA Curcio","year":"1990","unstructured":"Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol. 1990;300(1):5\u201325. https:\/\/doi.org\/10.1002\/cne.903000103.","journal-title":"J Comp Neurol"},{"issue":"2","key":"4510_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s1350-9462(00)00027-6","volume":"20","author":"DY Yu","year":"2001","unstructured":"Yu DY, Cringle SJ. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res. 2001;20(2):175\u2013208. https:\/\/doi.org\/10.1016\/s1350-9462(00)00027-6.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"4510_CR22","doi-asserted-by":"publisher","first-page":"015013","DOI":"10.1117\/1.NPh.7.1.015013","volume":"7","author":"K Kurokawa","year":"2020","unstructured":"Kurokawa K, Crowell JA, Zhang F, Miller DT. Suite of methods for assessing inner retinal Temporal dynamics across Spatial and Temporal scales in the living human eye. Neurophotonics. 2020;7(1):015013. https:\/\/doi.org\/10.1117\/1.NPh.7.1.015013.","journal-title":"Neurophotonics"},{"issue":"5","key":"4510_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.preteyeres.2012.04.004","volume":"31","author":"J Kur","year":"2012","unstructured":"Kur J, Newman EA, Chan-Ling T. Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease. Prog Retin Eye Res. 2012;31(5):377\u2013406. https:\/\/doi.org\/10.1016\/j.preteyeres.2012.04.004.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"4510_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1167\/iovs.10-6207","volume":"52","author":"M Hadziahmetovic","year":"2011","unstructured":"Hadziahmetovic M, Song Y, Wolkow N, Iacovelli J, Grieco S, Lee J, et al. The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration. Invest Ophthalmol Vis Sci. 2011;52(2):959\u201368. https:\/\/doi.org\/10.1167\/iovs.10-6207.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"4510_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4103\/0301-4738.98714","volume":"60","author":"S Simon","year":"2012","unstructured":"Simon S, Athanasiov PA, Jain R, Raymond G, Gilhotra JS. Desferrioxamine-related ocular toxicity: a case report. Indian J Ophthalmol. 2012;60(4):315\u20137. https:\/\/doi.org\/10.4103\/0301-4738.98714.","journal-title":"Indian J Ophthalmol"},{"key":"4510_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2415-14-88","volume":"14","author":"C Wu","year":"2014","unstructured":"Wu C, Yang C, Lai C, Wu W, Chen Y. Deferoxamine retinopathy: spectral domain-optical coherence tomography findings. BMC Ophthalmol. 2014;14:88. https:\/\/doi.org\/10.1186\/1471-2415-14-88.","journal-title":"BMC Ophthalmol"},{"key":"4510_CR27","doi-asserted-by":"publisher","unstructured":"Xue R, Liang S, Wan G. Hypoxia-related retinal\/choroidal vascular disorders: pathogenesis and mechanism. Chin Med J (Engl). 2025;3. https:\/\/doi.org\/10.1097\/CM9.0000000000003569.","DOI":"10.1097\/CM9.0000000000003569"},{"key":"4510_CR28","unstructured":"Zhang YX, Wei R, Lv ZW. Association of serum VEGF concentration with hematological malignancies. J Tongji Univ (Med Sci). 2005(6):42."},{"issue":"2","key":"4510_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.celrep.2014.09.003","volume":"9","author":"S Lim","year":"2014","unstructured":"Lim S, Zhang Y, Zhang D, et al. VEGFR2-mediated vascular dilation as a mechanism of VEGF-induced anemia and bone marrow cell mobilization. Cell Rep. 2014;9(2):569\u201380. https:\/\/doi.org\/10.1016\/j.celrep.2014.09.003.","journal-title":"Cell Rep"},{"key":"4510_CR30","doi-asserted-by":"publisher","first-page":"101469","DOI":"10.1016\/j.redox.2020.101469","volume":"34","author":"W Shu","year":"2020","unstructured":"Shu W, Baumann BH, Song Y, Liu Y, Wu X, Dunaief JL. Ferrous but not ferric iron sulfate kills photoreceptors and induces photoreceptor-dependent RPE autofluorescence. Redox Biol. 2020;34:101469. https:\/\/doi.org\/10.1016\/j.redox.2020.101469.","journal-title":"Redox Biol"},{"issue":"4","key":"4510_CR31","doi-asserted-by":"publisher","first-page":"e13579","DOI":"10.1111\/acel.13579","volume":"21","author":"Y Liu","year":"2022","unstructured":"Liu Y, Bell BA, Song Y, et al. Deuterated docosahexaenoic acid protects against oxidative stress and geographic atrophy-like retinal degeneration in a mouse model with iron overload. Aging Cell. 2022;21(4):e13579. https:\/\/doi.org\/10.1111\/acel.13579.","journal-title":"Aging Cell"},{"issue":"9","key":"4510_CR32","doi-asserted-by":"publisher","first-page":"130172","DOI":"10.1016\/j.bbagen.2022.130172","volume":"1866","author":"L Dos Santos","year":"2022","unstructured":"Dos Santos L, Bertoli SR, \u00c1vila RA, Marques VB. Iron overload, oxidative stress and vascular dysfunction: evidences from clinical studies and animal models. Biochim Biophys Acta Gen Subj. 2022;1866(9):130172. https:\/\/doi.org\/10.1016\/j.bbagen.2022.130172.","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"12","key":"4510_CR33","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1038\/s42255-023-00928-2","volume":"5","author":"M Maus","year":"2023","unstructured":"Maus M, L\u00f3pez-Polo V, Mateo L, Lafarga M, Aguilera M, De Lama E, et al. Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype. Nat Metab. 2023;5(12):2111\u201330. https:\/\/doi.org\/10.1038\/s42255-023-00928-2.","journal-title":"Nat Metab"},{"issue":"4","key":"4510_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.7499\/j.issn.1008-8830.2411001","volume":"27","author":"Committee of Thalassemia Prevention and Treatment, China Maternal and Child Health Association; Subspecialty Group of Hematology, Society of Pediatrics, Chinese Medical Association; China Thalassemia Prevention and Control Collaboration Network","year":"2025","unstructured":"Committee of Thalassemia Prevention and Treatment, China Maternal and Child Health Association; Subspecialty Group of Hematology, Society of Pediatrics, Chinese Medical Association; China Thalassemia Prevention and Control Collaboration Network. Editorial board of Chinese journal of contemporary Pediatrics. Guidelines for iron chelation therapy in thalassemia in China (2025). Zhongguo Dang Dai Er Ke Za Zhi. 2025;27(4):377\u201388. https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2411001.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"4510_CR35","doi-asserted-by":"publisher","unstructured":"Haghpanah S, Zekavat OR, Bordbar M, Karimi M, Zareifar S, Safaei S et al. Ocular findings in patients with transfusion-dependent \u03b2-thalassemia in southern Iran. BMC Ophthalmol. 2020;20(1):376. https:\/\/doi.org\/10.1186\/s12886-020-01647-y.","DOI":"10.1186\/s12886-020-01647-y"},{"key":"4510_CR36","unstructured":"Zhou H, Cai B, Li YM. To investigate of optic disks with refractive error. [J]. Chin J Strabismus Pediatr Ophthalmol. 2005(2):64\u20136578."},{"issue":"2","key":"4510_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.12376\/j.issn.2097-0501.2023.02.019","volume":"2","author":"HF Wang","year":"2023","unstructured":"Wang HF, Zhai ZF. Advances in Pseudoxanthoma Elasticum[J]. J Rare Dis. 2023;2(2):313\u20138. https:\/\/doi.org\/10.12376\/j.issn.2097-0501.2023.02.019.","journal-title":"J Rare Dis"},{"issue":"3","key":"4510_CR38","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/sj.eye.6700352","volume":"17","author":"C Incorvaia","year":"2003","unstructured":"Incorvaia C, Parmeggiani F, Costagliola C, Perri P, D\u2019Angelo S, Sebastiani A. Quantitative evaluation of the retinal venous tortuosity in chronic anaemic patients affected by beta-thalassaemia major. Eye (Lond). 2003;17(3):324\u20139. https:\/\/doi.org\/10.1038\/sj.eye.6700352.","journal-title":"Eye (Lond)"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04510-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04510-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04510-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:49:53Z","timestamp":1765536593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-025-04510-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4510"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04510-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of the Affiliated Hospital of Guangdong Medical University (approval number: KT2023-016-01). All procedures involving human participants were performed in accordance with the ethical standards of this committee and with the 1964 Helsinki Declaration and its later amendments. Written informed consent was obtained from all guardians, and assent was obtained from participants where appropriate, ensuring their voluntary participation. This study adheres to strict privacy protection measures to safeguard the personal information of all participants and their guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"690"}}